BSP Pharmaceuticals
Latina, Italy
Program data pending ClinicalTrials.gov matching
· Last scored 2026-11-02
79.5
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (15)
○ MHRA GMP
✓ HC GMP (5)
Quick Facts: BSP Pharmaceuticals
- Signal Score
- 79.5/100 (as of 2026-11-02)
- Quality Compliance
- 100.0/100 — Clean EMA record: 15 active GMP certificates (no deductions)
- Headquarters
- Latina, Italy
- Modalities
- Sterile Fill-Finish, Cytotoxics, ADC / Bioconjugation, Lyophilization
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About BSP Pharmaceuticals
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
Clean EMA record: 15 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 15 active GMP certificates (no deductions)
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2021-11-12)
EMA GMP Certificates15 on record
Most Recent HC OutcomeCompliant · 2023-05-12
HC Attribution5 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Clean EMA record: 15 active GMP certificates (no deductions)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSterile Fill-Finish, Cytotoxics, ADC / Bioconjugation, Lyophilization
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
63.0
Broad modality coverage (4 modalities)
Sites: Latina, IT
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Broad modality coverage (4 modalities)
BSP Pharmaceuticals FDA Inspection History
2021-11
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2021-11-12 |
BSP Pharmaceuticals SpA
Latina
Company-level
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
BSP Pharmaceuticals EMA GMP Compliance 15 certificates
2025-02
2024-10
2024-10
2024-10
2024-10
2024-10
2024-10
2024-10
2024-10
2024-10
2022-05
2022-05
2021-11
2019-11
2019-11
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| IT/42/H/2025 | Bsp Pharmaceuticals S.p.A. | Italy | 2025-02-21 | COMPLIANT |
| IT-API/12/H/2025 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/25/H/2025 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/83/H/2025 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/10/H/2026 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/45/H/2026 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/75/H/2026 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/87/H/2026 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/117/H/2026 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/132/H/2026 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/7/H/2023 | Bsp Pharmaceuticals S.p.A. | Italy | 2022-05-27 | COMPLIANT |
| IT-API/72/H/2024 | Bsp Pharmaceuticals S.p.A. | Italy | 2022-05-27 | COMPLIANT |
| IT-API/79/H/2022 | Bsp Pharmaceuticals S.p.A. | Italy | 2021-11-12 | COMPLIANT |
| IT-API/107/H/2021 | BSP PHARMACEUTICALS S.P.A. | Italy | 2019-11-22 | COMPLIANT |
| IT-API/54/H/2021 | BSP PHARMACEUTICALS S.P.A. | Italy | 2019-11-22 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Japan-accredited overseas site (PMDA)
sterile, general (non-sterile) · 1 site
- Latina Scalo, Italy · BSP Pharmaceuticals S.p.A. — sterile, general (non-sterile) · valid to Sep 12, 2031
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Frequently Asked Questions About BSP Pharmaceuticals
How many FDA inspections does BSP Pharmaceuticals have on record?
CDMO Signal tracks 1 FDA inspection for BSP Pharmaceuticals, sourced from the FDA inspection database. See the full inspection history above.
Has BSP Pharmaceuticals received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for BSP Pharmaceuticals.
Does BSP Pharmaceuticals hold EMA or MHRA GMP certificates?
CDMO Signal tracks 15 EMA GMP certificates for BSP Pharmaceuticals.
What is BSP Pharmaceuticals's CDMO Signal Score?
BSP Pharmaceuticals has a Signal Score of 80/100, based on quality, operations, financial stability, and capacity data.
Evaluating BSP Pharmaceuticals for a manufacturing program?
Use the free AI matchmaker to compare BSP Pharmaceuticals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
BioTechnique
York, Pennsylvania, USA
Sterile Fill-Finish, Lyophilization, Sterile Injectables, Cytotoxics, ADC / Bioconjugation, Biologics, Vaccines, Clinical Trial Manufacturing
AbbVie Contract Manufacturing
North Chicago, Illinois, United States
Small Molecule API, High-Potency APIs, Biologics, ADC / Bioconjugation, Sterile Fill-Finish, Lyophilization, Prefilled Syringes, Oral Solid Dose, Hot-Melt Extrusion, Oral Liquids, Topicals
Latina Pharma
Sermoneta (Latina), Italy
Small Molecule API, Oncology Products, Sterile Fill-Finish, Lyophilization, Oral Solid Dose
Content Group
Sant'Agata Bolognese, Bologna, Italy
Sterile Fill-Finish, Sterile Injectables, Semi-solids & Liquids, Lyophilization, Inhalation & Nasal, Veterinary
Adragos Pharma
Munich, Germany
Sterile Fill-Finish, Lyophilization, Sterile Injectables, Prefilled Syringes, Semi-solids & Liquids, Oral Solid Dose, Clinical Trial Manufacturing
Compare BSP Pharmaceuticals with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.